Our findings suggest an important contribution of the p66Shc orchestrates autophagy through MAMs and the cGAS/STING signaling pathway, highlighting the potential therapeutic strategy of targeted suppression of p66Shc-mediated autophagy for managing placental dysfunction in patients with GDM. Here, CGAS is linked to gestational diabetes.